DE602005016676D1 - Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas-suszeptibilitätssgen und dessen verwendung - Google Patents

Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas-suszeptibilitätssgen und dessen verwendung

Info

Publication number
DE602005016676D1
DE602005016676D1 DE602005016676T DE602005016676T DE602005016676D1 DE 602005016676 D1 DE602005016676 D1 DE 602005016676D1 DE 602005016676 T DE602005016676 T DE 602005016676T DE 602005016676 T DE602005016676 T DE 602005016676T DE 602005016676 D1 DE602005016676 D1 DE 602005016676D1
Authority
DE
Germany
Prior art keywords
obesity
human
adipositas
voltage
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005016676T
Other languages
English (en)
Inventor
Anne Philippi
Francis Rousseau
Elke Roschmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IntegraGen SA
Original Assignee
IntegraGen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IntegraGen SA filed Critical IntegraGen SA
Publication of DE602005016676D1 publication Critical patent/DE602005016676D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Electrotherapy Devices (AREA)
  • Eye Examination Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602005016676T 2004-06-14 2005-06-14 Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas-suszeptibilitätssgen und dessen verwendung Expired - Fee Related DE602005016676D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57882904P 2004-06-14 2004-06-14
PCT/IB2005/002356 WO2005123949A2 (en) 2004-06-14 2005-06-14 Human obesity susceptibility gene encoding a potassium voltage-gated channel and uses thereof

Publications (1)

Publication Number Publication Date
DE602005016676D1 true DE602005016676D1 (de) 2009-10-29

Family

ID=35395853

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016676T Expired - Fee Related DE602005016676D1 (de) 2004-06-14 2005-06-14 Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas-suszeptibilitätssgen und dessen verwendung

Country Status (10)

Country Link
US (1) US20080193923A1 (de)
EP (1) EP1756316B1 (de)
JP (1) JP2008502341A (de)
AT (1) ATE443160T1 (de)
AU (1) AU2005254806B2 (de)
CA (1) CA2568957A1 (de)
DE (1) DE602005016676D1 (de)
DK (1) DK1756316T3 (de)
IL (1) IL179744A0 (de)
WO (1) WO2005123949A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113671179B (zh) * 2021-09-02 2023-10-03 中国科学院深圳先进技术研究院 一种kcnab2自身抗体的检测用试剂盒及其检测方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185573A (en) * 1991-04-16 1993-02-09 Hewlett-Packard Company Method for focusing of magnetic resonance images
US5221900A (en) * 1991-04-30 1993-06-22 Hewlett-Packard Company Magnet structure for focusing of magnetic resonance images
US5252922A (en) * 1991-04-30 1993-10-12 Hewlett-Packard Company Radiofrequency focusing of magnetic resonance images
US6477398B1 (en) * 1997-11-13 2002-11-05 Randell L. Mills Resonant magnetic susceptibility imaging (ReMSI)
WO2001066800A2 (en) * 2000-03-07 2001-09-13 Whitehead Institute For Biomedical Research Human single nucleotide polymorphisms
US6682888B1 (en) * 2000-05-05 2004-01-27 Incyte Corporation Genes expressed in alzheimer's disease
WO2002028999A2 (en) * 2000-10-03 2002-04-11 Gene Logic, Inc. Gene expression profiles in granulocytic cells
AU2003279980A1 (en) * 2002-10-16 2004-05-04 Incyte Corporation Transporters and ion channels

Also Published As

Publication number Publication date
JP2008502341A (ja) 2008-01-31
WO2005123949A3 (en) 2006-03-16
DK1756316T3 (da) 2010-01-18
EP1756316B1 (de) 2009-09-16
AU2005254806A1 (en) 2005-12-29
IL179744A0 (en) 2007-05-15
ATE443160T1 (de) 2009-10-15
AU2005254806B2 (en) 2009-06-04
WO2005123949A2 (en) 2005-12-29
EP1756316A2 (de) 2007-02-28
CA2568957A1 (en) 2005-12-29
US20080193923A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
Apostolova et al. Associations of the top 20 Alzheimer disease risk variants with brain amyloidosis
Kober et al. Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors
Alcalay et al. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease
Nygaard et al. Cellular prion protein mediates the toxicity of β-amyloid oligomers: implications for Alzheimer disease
Agusti et al. Moving towards a treatable traits model of care for the management of obstructive airways diseases
Ghani et al. Association of long runs of homozygosity with Alzheimer disease among African American individuals
Gutmann Eliminating barriers to personalized medicine: learning from neurofibromatosis type 1
Keel et al. Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies
ATE382101T1 (de) Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen
WO2006087634A3 (en) Uses of human autism susceptibility gene encoding a kinase
EE200200049A (et) Polümorfismid inimese MDR-1 geenis ning nende kasutamine diagnostikas ja terapeutilistes rakendustes
DE602005013080D1 (de) Für prkcb1 kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung
DE602005016676D1 (de) Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas-suszeptibilitätssgen und dessen verwendung
DK1504125T3 (da) Humant fedmemodtagelighedsgen og anvendelser deraf
DE602006017045D1 (de) Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung
Rhee et al. Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus
WO2005021787A3 (en) Human obesity susceptibility gene and uses thereof
Tarantini et al. Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event
WO2005090600A3 (en) Human obesity susceptibility genes encoding peptide hormones and uses thereof
Miorelli et al. Psychiatric aspects of chronic physical disease
Tarlock et al. Functional properties of exon 17 KIT mutations in pediatric CBF AML predict for inferior outcome and enhanced response to tyrosine kinase inhibition: a report from the children's Oncology Group
Kubarieva et al. Marketing investigation of preventive therapy of patients with multiple sclerosis
Wolthers et al. Common Genetic Variants in Trypsin Regulating Genes Are Associated with AsparAginase-Associated Pancreatitis in Children with Acute Lymphoblastic Leukemia: A Ponte Di Legno Toxicity Working Group Study
Müller et al. HbA1c Levels, Body Weight Change, and Risk of Pancreatic Cancer Among Patients With Long-Standing Diabetes Mellitus: A Case-Control Study
Modoni et al. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c. 574A→ G mutation in KCNJ2

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee